Kosugi S
Department of Laboratory Medicine, Kyoto University School of Medicine.
Nihon Rinsho. 1998 Jul;56(7):1856-60.
Since 1993, a number of mutations of the thyrotropin receptor(TSHR) gene causing human diseases have been reported; activating TSHR somatic mutations causing autonomously functioning thyroid nodules, activating TSHR germ-line mutations causing familial non-autoimmune hyperthyroidism, and inactivating TSHR germ-line mutations causing hypothyroidism due to TSH unresponsiveness. Activating TSHR mutations increase second messenger signals without stimulation of TSH or thyroid stimulating antibody, conferring autonomous growth and function upon thyroid cells. Most of activating TSHR mutations are located in the transmembrane domain of the receptor. One of most important mechanisms how these mutants activate the receptor constitutively is that inter-helical bonding(s) maintained in the silent receptor is/are disrupted by the mutations. Further investigation of activating mutations will provide insight into normal activating mechanism of the receptor.
自1993年以来,已报道了许多导致人类疾病的促甲状腺激素受体(TSHR)基因突变;激活TSHR体细胞突变导致自主性甲状腺结节,激活TSHR种系突变导致家族性非自身免疫性甲状腺功能亢进,以及失活TSHR种系突变导致因TSH无反应而引起的甲状腺功能减退。激活TSHR突变在无TSH或甲状腺刺激抗体刺激的情况下增加第二信使信号,赋予甲状腺细胞自主生长和功能。大多数激活TSHR突变位于受体的跨膜结构域。这些突变体如何组成性激活受体的最重要机制之一是,沉默受体中维持的螺旋间键被突变破坏。对激活突变的进一步研究将有助于深入了解受体的正常激活机制。